National Cancer Institute; Amended Notice of Meeting

---
identifier: "/us/fr/2017-03448"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2017-03448"
section_name: "National Cancer Institute; Amended Notice of Meeting"
positive_law: false
currency: "2017-02-22"
last_updated: "2017-02-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2017-03448"
document_type: "notice"
publication_date: "2017-02-22"
agencies:
  - "Health and Human Services Department"
  - "National Institutes of Health"
fr_citation: "82 FR 11363"
fr_volume: 82
---


#  National Cancer Institute; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the National Cancer Institute Clinical Trials and Translation Research Advisory Committee, March 8, 2017, 8:00 a.m. to March 8, 2017, 3:00 p.m., National Institutes of Health, Building 31, C-Wing, 6th Floor, Rooms 9 and 10, 31 Center Drive, Bethesda, MD 20892 which was published in the *Federal Register* on January 11, 2017, 81 FR 3342.

This meeting notice is amended to change the meeting format and start and end times. The meeting will now be held virtually from 11:00 a.m. to 1:30 p.m. due to a change in the agenda which reduced the time required for deliberation and discussion. The meeting will still be held at the National Institutes of Health, Building 31, C-Wing, 6th Floor, Rooms 9 and 10, 31 Center Drive, Bethesda, MD 20892 and can also be accessed via NIH Videocast at *https://videocast.nih.gov.* This meeting is open to the public.

Dated: February 16, 2017.

Melanie J. Gray-Pantoja,

Program Analyst, Office of Federal Advisory Committee Policy.